hVIVO Plc acquires CRS Clinical Research Services Berlin
Phase I/II clinical trials · Berlin, Germanyacquired byhVIVO Plc
advised by
- Buy-side
- Grant Thornton(Tax Due Diligence, Steuern)
hVIVO Plc from London acquires CRS Clinical Research Services Berlin, a Phase I/II unit focused on dermatology and women's health. hVIVO is already present in Germany with CRS Mannheim and CRS Kiel.
- Buyer
- hVIVO Plc
- Target
- CRS Clinical Research Services Berlin, Berlin
- Type
- Strategic
- Sector
- Healthcare & Medtech
- Country
- Germany
- First reported
- 01/10/2026
- Buy-side
- Grant Thornton, according to the source
- Source
- grantthornton.de
Deal-Radar no. 42-098 · added in Week 42/2026, first reported on 01/10/2026 · publicly reported, without guarantee · SourcingClub was not involved in this transaction. Report an error · Method
Transactions by hVIVO Plc
So far this is the only transaction by hVIVO Plc published in the Deal-Radar. New deals are added every Monday.
Strategic and succession in Week 42/2026
All deals in October 2026Every Monday, all deals of the previous week, with source.
Information from public sources, without guarantee and without claim to completeness. No investment or legal advice. Published on 19 October 2026.